NCRI Press Release, 8 November 2010
Date published: Nov 08 2010
Test selects 60 per cent of women with inherited ovarian cancer who could benefit from ‘smart’ drug
Download the attachment
Recent Tweets
-
Members of the NCRI #UpperGI_Group have authored this paper, Sex difference in patients with biliary tract cancer r… https://t.co/MfgSFer4tq
2 days ago -
A number of members of the NCRI #UpperGI_Group have been involved in a study looking at small oligonucleotide drugs… https://t.co/wgFZewmXHs
2 days ago -
Today at @ASCO #GI20 Somnath Mukherjee @UniofOxford will be presenting a trial developed by the NCRI #UpperGI_Group… https://t.co/4AIV0KZHLz
2 days ago
- 26 Nov 2019CM-Path - Application for Consumer Membership (Deadline - 1st January 2020)
- 20 Nov 2019With its new chair, Professor David Harrison, at the helm, CM-Path share top priorities
- 19 Jul 2019Consumer (Patient / Carers) vacancies for NCRI Groups available. Apply today!
- 20 May 2019Celebrating ten years of NCRI’s Clinical and Translational Radiotherapy Research Group
- 29 Apr 2019NCRI and The British Society for Immunology announce new partnership
- 14 Mar 2019Register now for the NCRI CTU Annual Trials Meeting: 17 June 2019
RSS Feed